Effects	O
of	O
doxycycline	O
on	O
in	O
vitro	O
growth	O
,	O
migration	O
,	O
and	O
gelatinase	O
activity	O
of	O
breast	B-Cell
carcinoma	I-Cell
cells	I-Cell
.	O

Metastatic	O
disease	O
is	O
one	O
of	O
the	O
major	O
causes	O
of	O
death	O
from	O
cancer	B-Cancer
in	O
human	O
beings	O
.	O

Several	O
enzyme	O
systems	O
have	O
been	O
implicated	O
in	O
the	O
metastatic	O
process	O
,	O
but	O
the	O
metalloproteinases	O
(	O
MPs	O
)	O
appear	O
to	O
be	O
the	O
major	O
group	O
involved	O
in	O
most	O
instances	O
of	O
neoplastic	B-Cancer
invasion	O
.	O

Increased	O
MP	O
activity	O
has	O
been	O
correlated	O
with	O
the	O
metastatic	O
potential	O
of	O
many	O
cancers	B-Cancer
,	O
including	O
breast	B-Cancer
cancer	I-Cancer
.	O

MPs	O
also	O
play	O
a	O
role	O
in	O
tumor	B-Cancer
angiogenesis	O
.	O

Tetracyclines	O
are	O
antimicrobial	O
agents	O
that	O
can	O
suppress	O
MP	O
activity	O
in	O
a	O
variety	O
of	O
tissues	B-Tissue
,	O
including	O
gingiva	B-Multi-tissue_structure
,	O
bone	B-Tissue
,	O
and	O
cartilage	B-Tissue
.	O

Several	O
reports	O
have	O
indicated	O
that	O
tetracyclines	O
can	O
suppress	O
tumor	B-Cancer
MPs	O
as	O
well	O
.	O

A	O
synthetic	O
tetracycline	O
,	O
doxycycline	O
,	O
inhibits	O
migration	O
of	O
human	O
MDA	B-Cell
-	I-Cell
MB	I-Cell
-	I-Cell
435	I-Cell
breast	I-Cell
adenocarcinoma	I-Cell
cells	I-Cell
through	O
a	O
reconstituted	O
basement	B-Cellular_component
membrane	I-Cellular_component
(	O
Matrigel	O
)	O
,	O
an	O
assay	O
used	O
as	O
an	O
in	O
vitro	O
surrogate	O
for	O
the	O
in	O
vivo	O
process	O
of	O
tumor	B-Cancer
invasion	O
through	O
basement	B-Cellular_component
membranes	I-Cellular_component
.	O

Additionally	O
,	O
doxycycline	O
diminishes	O
the	O
proliferation	O
of	O
this	O
breast	B-Cell
cancer	I-Cell
cell	I-Cell
line	I-Cell
and	O
also	O
decreases	O
its	O
gelatinolytic	O
activity	O
,	O
as	O
determined	O
by	O
gel	O
zymography	O
.	O

